2m 2m 2m 2m 2m 2m - S&P 600$1,709.07
2m
ASCENDIS PHARMA BR (ASND)
NASDAQ
$275.75+$0.36 (+0.13%)
Price as of Nov 13, 2026 7:30 PM EST- $17.7BMarket Cap
- 34.73%1-Year Change
- BiotechnologyIndustry
ASCENDIS PHARMA BR (ASND)
$275.75+$0.36 (+0.13%)
Earnings Score
Valuation | ASND | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | ASND | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -7.96% | ||
12-Month Momentum | 9.77% | ||
3-Month Risk Adjusted Momentum | -46.93% | ||
12-Month Risk Adjusted Momentum | 25.87% |
True Yield
Valuation | ASND | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.27% |
Financial Health Score
Valuation | ASND | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 6 |